Ritonavir + Lopinavir Tablet 50/200mg

Ritonavir + Lopinavir Tablet 50/200mg is a widely prescribed antiretroviral medication used in the management of Human Immunodeficiency Virus (HIV) infection. This fixed-dose combination belongs to the protease inhibitor class of drugs and plays a crucial role in controlling viral replication when used as part of combination antiretroviral therapy (ART). Lopinavir works by inhibiting the HIV protease enzyme, which is essential for the virus to multiply, while ritonavir enhances the effectiveness of lopinavir by increasing its concentration in the bloodstream.

This pharmaceutical formulation is commonly recommended for adults and pediatric patients under the supervision of a healthcare professional. Regular use of these tablets helps reduce viral load, improve immune function, and slow the progression of HIV to AIDS. It is not a cure for HIV but significantly supports long-term disease management and improves quality of life when taken as prescribed.

This product ensures consistent potency, stability, and therapeutic performance. Ritonavir (50 mg) + Lopinavir (200 mg) Tablet is typically administered orally and should be taken exactly as directed by a physician to achieve optimal results. As a trusted pharmaceutical product, it remains a key component in modern HIV treatment regimens worldwide, supporting effective and reliable antiviral therapy.

Product Features

• Combination antiretroviral product containing Ritonavir 50mg and Lopinavir 200mg
• It belongs to the protease inhibitor class used in HIV infection management
• Ritonavir boosts Lopinavir levels for enhanced antiviral effectiveness
• Helps reduce HIV viral load and supports immune system function
• Suitable for use as part of combination antiretroviral therapy (ART)

How It Helps

• Inhibits HIV protease enzyme, preventing the virus from multiplying in the body
• Helps lower the HIV viral load and slows the progression of the infection
• Supports improvement of immune function when used as part of ART therapy
• Enhances treatment effectiveness through Ritonavir-boosted Lopinavir action